ULSBA Tracks Nearly 500 Risk Contacts After Three Confirmed Measles Cases Surface in Beja — 120 Post-Exposure Vaccinations Roll Out as Bruno Pinto Rebelo Confirms the Surto Definition

The Unidade Local de Saúde do Baixo Alentejo confirmed on Monday 18 May 2026 that three measles cases identified across the Concelho de Beja since the start of April have an epidemiological link to one another, and that the public-health response has identified close to 500 risk contacts in the surrounding population. Bruno Pinto Rebelo, the ULSBA Autoridade de Saúde Local who briefed PÚBLICO and RTP through Monday afternoon, classified the cluster as a 'surto' under the standard ECDC definition — a sudden and unexpected rise in cases of a notifiable disease in a defined geographic area within a short time window — and confirmed that the contact-tracing operation has so far delivered post-exposure vaccinations to more than 120 of the identified contacts.

The three confirmed cases sit between 30 and 55 years old, an age band that maps to the cohort that received only one childhood measles dose before the Programa Nacional de Vacinação moved to the two-dose schedule, and the operational implication is that ULSBA is treating the population aged roughly 28 to 60 as the priority intervention group for catch-up immunisation in the affected freguesias. Two of the three confirmed cases were entirely unvaccinated. The third was a vaccinated adult, which Rebelo framed as a reminder that no vaccine is 100% effective even in a high-coverage population — and which the DGS will fold into its national surveillance file under the Programa Nacional de Eliminação do Sarampo.

What the ULSBA Operation Looks Like on the Ground

The contact-tracing piece is, by ULSBA's standards, the largest single-cluster public-health response in the Baixo Alentejo since the 2020 COVID waves. The 500-contact universe was built out from the three index cases by combining three data streams: the contacts each patient could identify from the 14 days preceding symptom onset, the workplace and family-network maps reconstructed by the saúde pública team, and the patient-visit log at the ULSBA's primary-care and emergency points in Beja for the four-week window before the first laboratory confirmation. Of those 500-odd contacts, ULSBA has verified the immunisation status of every single one, has notified almost all by telephone, and has prioritised the call-outs by two axes — age (children first) and prior vaccination status (zero or one dose first).

The 120 post-exposure vaccinations administered so far were given under the standard DGS norm that allows the trivalente VASPR — sarampo, papeira, rubéola — to act as a post-exposure prophylactic if administered within 72 hours of exposure. The campaign has run through the four ULSBA primary-care centres in Beja — USF Planície, UCSP Beja I, UCSP Beja II and the Centro de Saúde — with after-hours appointments at the Hospital José Joaquim Fernandes urgência for shift-workers and for the agricultural-labour cohort that anchors much of the Concelho's working-age population.

Hospitalisation has not been formally confirmed by ULSBA for the three index cases as of Monday afternoon, and the agency declined to disclose details about the cases' professional or social settings to avoid identification in a relatively small population. The conjunctival-and-rash phase of measles typically resolves within 7 to 10 days in otherwise-healthy adults, but the disease still carries a 1-in-1,000 encephalitis risk and a 1-in-500 pneumonia risk in the 30-to-55 bracket, particularly for the unvaccinated. ULSBA's clinical-management protocol now mirrors the DGS-published flow-chart for adult measles, with SNS 24 (808 24 24 24) as the front-door triage line for anyone with a rash, fever above 38.5°C, conjunctivitis and a recent presence in Beja.

The European Context

The Beja surto sits inside a Europe-wide measles resurgence that has been building since 2024. The ECDC's most recent monthly report, published 9 February 2026, tallied 7,655 confirmed measles cases across 30 EU and EEA countries during 2025, with Romania, France and Italy carrying the bulk of the load. Portugal recorded 21 confirmed cases over the full 2025 calendar, putting it among the lowest-incidence countries in the EU on a per-capita basis but still well above the elimination-threshold case-count of fewer than 10 confirmed cases per million inhabitants on a rolling 12-month basis. The 2024 baseline was 4 confirmed Portuguese cases — the 2025 jump to 21 was already concerning enough for the DGS to flag the trajectory in its Saúde em Números 2025 report; the Beja cluster is the first sub-national surto registered in 2026.

National vaccination coverage in Portugal sits at 95.6% for the first VASPR dose and 93.2% for the second according to DGS's most recent published series (2024 cohort), both above the 95% herd-immunity threshold for the first dose but the second-dose figure narrowly below it. Coverage in the Baixo Alentejo Saúde Pública region is structurally lower — at 92.4% and 90.1% respectively — reflecting the older age structure of the population and the lower rate of paediatric births that anchors the PNV. The age band of the three Beja cases is a near-perfect fit for the cohort that received only one dose under the pre-1990 schedule, and that has not seen a catch-up campaign since the late-1990s sweep.

Why a Vaccinated Case Sits Inside the Cluster

Rebelo's framing of the one vaccinated case — 'studies show very high but not absolute protection from two doses' — is the line that public-health authorities have used in every European measles surto of the past 18 months. The full-coverage two-dose efficacy is around 97% for sarampo, which means roughly 3% of fully-vaccinated adults remain susceptible. In a cluster of 500 contacts, even at 95% coverage and 97% per-dose efficacy, the residual susceptible cohort is statistically 25 to 35 people, which is consistent with the case-count outcome ULSBA has observed. The vaccinated case does not signal vaccine failure in any meaningful policy sense — it signals that vaccine coverage and vaccine efficacy together explain the cluster size, and that the marginal protection still depends heavily on the surrounding unvaccinated population staying small.

The single vaccinated case will be folded into the DGS's national post-marketing surveillance file under the standard EVDS — European Vaccine Data System — reporting requirement, with confirmation of the vaccination series, the laboratory genotype of the patient's measles strain and the time-since-second-dose interval as the three variables that will be sent through to the ECDC. None of those data points alters the recommended PNV schedule, which keeps the two-dose VASPR at 12 months and 5 years.

What This Means for Foreign Residents in the Alentejo and Beyond

• If you live in the Concelho de Beja or have visited in the last four weeks: check your VASPR status. Adults born after 1968 in Portugal should have had two doses; UK and US adults of the same vintage typically have at least one MMR dose, but the second-dose coverage is patchier in those countries. Your boletim de vacinas — paper or via the SNS 24 portal — will show the dates; if you have one or zero doses, contact your ULS centro de saúde directly through their vaccination line rather than going through SNS 24, because ULSBA is fast-tracking catch-up appointments for the affected population.
• If you have a child under 5 in the household: the second VASPR dose is given at age 5 under the PNV. The first dose at 12 months provides about 93% protection — strong but not absolute — so children between 12 months and 5 years in the Baixo Alentejo are inside the at-risk population. ULSBA's catch-up appointment line accepts foreign-resident parents on the same terms as Portuguese nationals, with the child's SNS Número de Utente as the only required identifier.
• If you are a non-resident visitor in the Alentejo this month: the festival calendar around Beja includes the Ovibeja agricultural fair window, several azulejos-and-cante alentejano cultural-tourism circuits, and a busy schedule of accommodation-rural turnover at private quintas. None of those activities is on the ULSBA risk list because the three index cases have not been linked to specific public events, but visitors with one or zero VASPR doses should still travel with the documented dose history available — Portugal does not require proof of measles vaccination at entry, but the SNS 24 line will ask for it on triage.
• If you carry private health insurance: the VASPR is covered by SNS for residents on the standard PNV schedule at no cost, including for foreign-resident children under 18. Private-health insurance typically also covers post-exposure VASPR through the Convencionados network, but the practical reality is that the SNS catch-up campaign is faster than the private route because ULSBA has dedicated vaccination slots open all week.
• If you have been in contact with someone who has measles symptoms: the SNS 24 (808 24 24 24) line is the right first call, regardless of where in the country you are based. If the triage assesses you as a possible exposure, the call-line will route you to the local ULS for testing or for post-exposure VASPR within the 72-hour window. For foreign-resident expats, the call is taken in English on shifts where the triage stack supports it; outside those windows the line will route to a Portuguese-only operator.

The ULSBA operation will run for at least another two incubation cycles — 21 days each — before Rebelo declares the surto closed, which would push the earliest formal closure to early July 2026 if no further cases surface. The DGS will likely fold the Beja cluster into a national surveillance note in the coming weeks, and the Programa Nacional de Eliminação do Sarampo is on track to publish its annual review around the same time the broader summer-2026 communicable-disease bulletin lands. For now the operational picture is contained, the contact-tracing universe is fully mapped, and the vaccination sweep — among the largest single-cluster post-exposure campaigns Portugal has run since the 2018 Algarve outbreak — has so far delivered the response the ECDC framework calls for.